Albion News

Processors are showing increasing interest in installing wireless instruments. However, reliance on batteries and the cost of replacing them is causing some concerns. So, chemical makers should welcome rapidly emerging developments that enable vibrations or heat gradients to scavenge power that then can supplement or even supplant batteries. Already, a number of sites are pioneering use of such energy harvesting with wireless devices. read more
UK VC firm Albion has sold Nelson House, a mental health rehabilitation hospital to a joint venture formed by Care UK and Sussex Partnership NHS Foundation Trust for £8m. The sale generated a £2m profit, equating to a return of approximately 1.4 times their investment and an IRR of 18.3 per cent in under two years. A new hospital, Nelson House opened in May 2012 and was backed by Orchard Portman Hospitals and Albion. Albion in conjunction with its management team, Orchard Portman Hospitals, identified the South Coast as an area of under provision for independent mental health hospitals... read more
With the laudable aim of balancing the Budget over the longer term, pensions were bound to have to share part of the pain. However, the Chancellor’s announcement in his Autumn Statement to reduce the lifetime allowance and annual savings limits on pension savings from £1.5m to £1.25m and £50,000 to £40,000 respectively was presented as affecting just a small minority of those approaching retirement. In reality it will affect many more than might be imagined. This is because his analysis ignores the impact that the reductions will have on a large portion of younger workers who are some way off... read more
Albion is one of the UK’s largest venture capitalists has invested up to £2m in MyMeds&Me Ltd, a healthcare software as a service (“SaaS”) company, that provides a web-based solution for the capture of adverse event, product complaint and targeted medical information for pharmaceutical companies. The pharmaceutical industry processed around six million such events last year and the volume has grown at 10 – 15% p.a. over the last five years.  MyMeds&Me was established in 2011 by three senior pharmaceutical industry executives, Stephen Powell, Andrew Rut and Trevor Gibbs, who identified... read more
Albion is pleased to announce the successful sale of its six cinema investments for approximately £12.5 million. Funds managed or advised by Albion initially invested £1.2 million alongside City Screen Limited, the UK’s leading art-house cinema operator, to develop the Cambridge Arts Picturehouse in 1999 and subsequently invested further funds to develop the Picturehouse at FACT in Liverpool in 2002, the Greenwich Picturehouse in 2004, The Ritzy in Brixton and the Exeter Picturehouse in 2005 and Cinema City in Norwich in 2007, with additional funds invested in 2009 to enable the cinemas to... read more
Albion, one of the UK’s largest venture capitalists has invested £2.6m in Proveca, a specialist pharmaceutical company that develops innovative and technically complex new pharmaceuticals, largely for children.  Proveca, which was established in 2010 by Simon Bryson and Dr Helen Shaw, focuses on the re-engineering of existing generic medicines to make them appropriate for use by young people, many of whom will have chronic conditions which require on-going drug regimes. The company is currently developing medicines for children in the fields of cardiology, neurology and pain management.  Dr... read more
Abcodia swept the board at the Startups Awards 2012 by scooping three top prizes, as well as being honoured as the overall NatWest Startups Business of the Year, for its pioneering work in cancer screening. Abcodia won every award that it was shortlisted for – ‘Angel or VC-backed Business of the Year’, ‘Innovative Business of the Year’, and ‘Business Woman of the Year’ for its CEO Dr Julie Barnes. Abcodia, an innovative world leader in biomarker validation for cancer screening, has exclusive IP commercialisation rights to a biobank created by researchers at UCL with five million serum samples... read more
Albion has invested £1.3 million in partnership with Welsh based developer, Dragon Hydro Limited, to fund the development of a single 300kW hydropower scheme on the Afon Cadair river in the county of Gwynedd in Wales. The site in Wales will benefit from the Feed-in-Tariff regime and is expecting to generate its first electricity in Q3 2013. The installation is forecast to generate an average 1,300MWh of electricity per year, enough to power up to 300 households. This investment is Albion’s seventh investment into renewable energy and continues Albion’s strategy of expanding into this sector.... read more

Pages